Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > going forward , new ceo

<< Previous

Bullboard Posts

Next >>

Comment by menoalittleon Aug 22, 2021 2:46pm

225 Views

Post# 33746353

RE:RE:RE:RE:going forward , new ceo

>> That animal research has now been going on for 4 or 5 months so they must have some subsrantial results. I think something on that could come at any time now. Even if only an announcement of a gov. grant to pay for the research. That could do wonders for the share price.

Amen. That'd be really, really beautiful.

<< Previous

Bullboard Posts

Next >>

How a small-cap tech stock is broadening MRI technology